|
|
Volumn 41, Issue SUPPL. 2, 1997, Pages
|
|
The lack of respiratory effects of the ocular hypotensive drug latanoprost in patients with moderate-steroid treated asthma
a
|
|
Author keywords
adrenoreceptor agonist; asthma; beta 2 adrenergic agonists; corticosteroids; glaucoma; latanoprost
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CORTICOSTEROID;
EYE DROPS;
LATANOPROST;
PLACEBO;
SALBUTAMOL;
THEOPHYLLINE;
ADULT;
AEROSOL;
AGED;
ASTHMA;
BRONCHOSPASM;
CARDIOVASCULAR EFFECT;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FORCED EXPIRATORY VOLUME;
GLAUCOMA;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
INTRAOCULAR DRUG ADMINISTRATION;
MALE;
PEAK EXPIRATORY FLOW;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
SUBCONJUNCTIVAL DRUG ADMINISTRATION;
TOPICAL DRUG ADMINISTRATION;
|
|
EID: 0030937471
PISSN: 00396257
EISSN: None
Source Type: Journal
DOI: 10.1016/s0039-6257(97)80017-3 Document Type: Conference Paper |
|
Times cited : (33)
|
|
References (26)
|
